TEX2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.386400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.503800E-01
Normal-vs-Stage2
9.229400E-01
Normal-vs-Stage3
2.795600E-01
Normal-vs-Stage4
7.901600E-01
Stage1-vs-Stage2
6.599000E-01
Stage1-vs-Stage3
1.315200E-01
Stage1-vs-Stage4
9.000400E-01
Stage2-vs-Stage3
2.125000E-01
Stage2-vs-Stage4
6.136000E-01
Stage3-vs-Stage4
1.255630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.620000E-01
Normal-vs-AfricanAmerican
4.078000E-01
Normal-vs-Asian
7.544600E-01
Caucasian-vs-AfricanAmerican
2.161600E-01
Caucasian-vs-Asian
7.242200E-01
AfricanAmerican-vs-Asian
2.024800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.080800E-01
Normal-vs-Female
9.771000E-01
Male-vs-Female
7.509800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.971200E-01
Normal-vs-Age(41-60Yrs)
7.402000E-01
Normal-vs-Age(61-80Yrs)
8.305600E-01
Normal-vs-Age(81-100Yrs)
4.980400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.665600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.202000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.080800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.452200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.873700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.042600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.862600E-01
Normal-vs-Daily Drinker
2.656200E-01
Normal-vs-Weekly Drinker
6.747400E-01
Normal-vs-Occasional Drinker
7.780400E-01
Normal-vs-Social Drinker
6.739400E-01
Non Drinker-vs-Daily Drinker
1.905230E-01
Non Drinker-vs-Weekly Drinker
8.181800E-01
Non Drinker-vs-Occasional Drinker
9.872600E-01
Non Drinker-vs-Social Drinker
1.678430E-01
Daily Drinker-vs-Weekly Drinker
3.180800E-01
Daily Drinker-vs-Occasional Drinker
2.142800E-01
Daily Drinker-vs-Social Drinker
2.028300E-02
Weekly Drinker-vs-Occasional Drinker
8.367400E-01
Weekly Drinker-vs-Social Drinker
1.546390E-01
Occasional Drinker-vs-Social Drinker
1.994560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.184610E-01
Normal-vs-Grade 2
1.455760E-01
Normal-vs-Grade 3
7.820000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.946800E-01
Grade 1-vs-Grade 3
7.261800E-01
Grade 1-vs-Grade 4
1.184610E-01
Grade 2-vs-Grade 3
8.017600E-01
Grade 2-vs-Grade 4
1.455760E-01
Grade 3-vs-Grade 4
7.820000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.642800E-01
Normal-vs-NonDiabetic
8.747800E-01
Diabetic-vs-NonDiabetic
4.683000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.504600E-01
Normal-vs-NoPancreatitis
8.644000E-01
Pancreatitis-vs-NoPancreatitis
6.163800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.723400E-01
Normal-vs-N1
8.623000E-01
N0-vs-N1
5.819800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.308200E-01
Normal-vs-TP53-NonMutant
7.251200E-01
TP53-Mutant-vs-TP53-NonMutant
2.000600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
